University Host Session: Via the DARPA P3 and PREPARE programs and other funding sources, Georgia Tech is developing mRNA encoded antibody and CRISPR based therapies for treating and preventing viral infections. In addition, strides have been made to improve low-cost approaches to ultrasensitive pathogen detection.